AstraZeneca Plc – Strategy, SWOT and Corporate Finance Report

AstraZeneca Plc – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360Ëš view of the company.

AstraZeneca plc (AstraZeneca) is a biopharmaceutical company that endeavors to discover, produce and commercialize a wide range of prescription drugs. It focuses on therapy areas including respiratory; cardiovascular and renal and metabolic diseases; and cancer, besides autoimmune, infection and neurological diseases. The company’s product portfolio includes biologics, prescription pharmaceuticals and vaccines. AstraZeneca sells its products through wholly-owned local marketing companies, distributors and local representative offices. The company markets its products to primary care and specialty care physicians. The company operates in Europe, the Americas, Asia, Africa and Australasia. AstraZeneca is headquartered in Cambridge, Cambridgeshire, the UK.

Scope

Detailed information on AstraZeneca Plc required for business and competitor intelligence needs

A study of the major internal and external factors affecting AstraZeneca Plc in the form of a SWOT analysis

An in-depth view of the business model of AstraZeneca Plc including a breakdown and examination of key business segments

News about AstraZeneca Plc, such as business expansion, restructuring, and contract wins

Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

Gain understanding of AstraZeneca Plc and the factors that influence its strategies.

Track strategic initiatives of the company and latest corporate news and actions.

Assess AstraZeneca Plc as a prospective partner, vendor or supplier.

Support sales activities by understanding your customers' businesses better.

Stay up to date on AstraZeneca Plcs business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

Takeda Pharmaceutical Co Ltd

Shire Plc

Sanofi

Pfizer Inc

Novo Nordisk AS

Novartis AG

Merck & Co Inc

Johnson & Johnson

GlaxoSmithKline Plc

Gilead Sciences Inc

F. Hoffmann-La Roche Ltd

Daiichi Sankyo Co Ltd

Bristol-Myers Squibb Co

Astellas Pharma Inc

Amgen Inc

AbbVie Inc

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

AstraZeneca Plc - Key Facts

AstraZeneca Plc - Key Employees

AstraZeneca Plc - Key Employee Biographies

AstraZeneca Plc - Major Products and Services

AstraZeneca Plc - History

AstraZeneca Plc - Company Statement

AstraZeneca Plc - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Joint Venture

Section 2 Company Analysis

Company Overview

AstraZeneca Plc - Business Description

Business Segment: Biopharmaceuticals

Overview

Performance

Business Segment: Externalisation Revenue

Overview

Performance

Geographical Segment: Asia, Africa & Australasia

Target Markets

Performance

Geographical Segment: Continental Europe

Target Markets

Performance

Geographical Segment: The Americas

Target Markets

Performance

Geographical Segment: UK

Performance

R&D Overview

AstraZeneca Plc - Corporate Strategy

AstraZeneca Plc - SWOT Analysis

SWOT Analysis - Overview

AstraZeneca Plc - Strengths

AstraZeneca Plc - Weaknesses

AstraZeneca Plc - Opportunities

AstraZeneca Plc - Threats

AstraZeneca Plc - Key Competitors

Section 3 Company Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Performance Chart

Financial Performance

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts

Section 4 Company’s Lifesciences Financial Deals and Alliances

AstraZeneca Plc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

AstraZeneca Plc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

AstraZeneca Plc, Recent Deals Summary

Section 5 Company’s Recent Developments

Mar 25, 2019: AstraZeneca's Forxiga garners EU approval in type 1 diabetes

Mar 25, 2019: EU approves AstraZeneca's drug for adjunct use in Type-1 diabetes

Mar 14, 2019: AstraZeneca showcases next-generation Oncology pipeline addressing unmet patient needs at AACR Annual Meeting

Mar 14, 2019: AstraZeneca: Appointment of M s. Sarah Wang as an additional director

Mar 12, 2019: AstraZeneca, Seres Therapeutics to study new cancer therapy approach

Mar 11, 2019: AstraZeneca to Present New Cardiovascular Data on FARXIGA in Type 2 Diabetes At ACC 2019

Feb 27, 2019: Top pharma executives testify before US Senate over high prices

Feb 20, 2019: Study on regenerative angiogenesis in humans shows encouraging results

Feb 14, 2019: AstraZeneca announces full-year and Q4 2018 results

Feb 14, 2019: “MedImmune” brand to be retired as biologics integrate into AstraZeneca’s new R&D structure

Section 6 Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer

List of Tables

AstraZeneca Plc, Key Facts

AstraZeneca Plc, Key Employees

AstraZeneca Plc, Key Employee Biographies

AstraZeneca Plc, Major Products and Services

AstraZeneca Plc, History

AstraZeneca Plc, Subsidiaries

AstraZeneca Plc, Joint Venture

AstraZeneca Plc, Key Competitors

AstraZeneca Plc, Ratios based on current share price

AstraZeneca Plc, Annual Ratios

AstraZeneca Plc, Annual Ratios (Cont…1)

AstraZeneca Plc, Annual Ratios (Cont…2)

AstraZeneca Plc, Interim Ratios

AstraZeneca Plc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

AstraZeneca Plc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

AstraZeneca Plc, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List of Figures

AstraZeneca Plc, Performance Chart (2014 – 2018)

AstraZeneca Plc, Ratio Charts

AstraZeneca Plc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

AstraZeneca Plc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

    Pricing

Discounts available for multiple purchases.

reportstore@marketline.com
+44 20 7947 2960

Saved reports